相关实验视频

Updated: May 23, 2025

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

抑制海马中的5-HT_2C受体可以挽救小鼠的EphB2-依赖性记忆障碍

Subhajit Jana¹, Sailendrakumar Kolatt Chandran¹, Kobi Rosenblum¹

¹Sagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.

European journal of pharmacology

|May 15, 2025

概括

在EphB2缺乏的小鼠中,长期记忆 (LTM) 的损伤可以通过阻断5-HT2C 血清素受体来恢复. 这表明记忆是不可访问的,不是丢失的,并为神经系统疾病提供潜在的治疗途径.

科学领域:

神经科学是一个神经科学.
分子生物学分子生物学
遗传学遗传学是一个

背景情况:

对于神经元功能,如突触传输和形态发生,EphB2受体氨酸激酶是至关重要的.
埃弗B2功能障碍与神经系统疾病有关,包括阿尔茨海默病和自闭症,通常与记忆力缺陷和随着年龄的增长而减少表达有关.
在阿尔茨海默病的小鼠模型中,EphB2的枯竭会导致记忆障碍.

研究的目的:

调查EphB2前向信号在听觉恐惧调节的长期记忆 (LTM) 中的作用.
探索向5-HT2C血清素受体的潜力,以挽救EphB2缺乏小鼠的记忆缺陷.

主要方法:

在EphB2突变 (EphB2^lacZ/lacZ) 和野生型小鼠中进行听觉恐惧调节和长期记忆测试.
在记忆恢复或训练之前,对5-HT2C抗剂SB 242084或激动剂MK-212进行海马微注射.
对海马金字塔神经元刺激性的电生理学分析.

主要成果:

埃弗B2^lacZ/lacZ小鼠表现出受损的LTM用于听觉恐惧调节.
在EphB2^lacZ/lacZ小鼠中,将SB 242084微注射到海马中可以挽救LTM,而不仅仅影响结.
SB 242084治疗增加了海马体金字塔神经元刺激能力,特别是在EphB2^lacZ/lacZ小鼠中.
当在训练前或在野生型小鼠中使用时,5-HT2C抗剂是无效的,而激动剂MK-212在野生型小鼠中没有影响LTM.

结论:

在EphB2^lacZ/lacZ小鼠中的记忆缺陷是由于无法访问而不是失去.
准5-HT2C 血清素受体可以恢复无法访问的恐惧记忆.
这一发现为与脑疾病中的EphB2功能障碍相关的记忆障碍提供了潜在的治疗策略.

关键词:

5-HT ((2C) 血清素受体的受体在 EphB2 中.恐惧是对恐惧进行调节的.在海马体内,海马体长期记忆长期记忆长期记忆

更多相关视频

A Method of Nodose Ganglia Injection in Sprague-Dawley Rat

A Method of Nodose Ganglia Injection in Sprague-Dawley Rat

Published on: November 25, 2014

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

相关概念视频

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Drugs Affecting Neurotransmitter Release or Uptake

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...

Drugs Affecting Neurotransmitter Synthesis

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...

Adrenergic Agonists: Indirect-Acting Agents

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...